Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.57 +0.01 (+1.41%)
At close: Nov 11, 2026 · 4:00 PM EST

Rani Therapeutics Holdings (RANI) Long-Term Debt Issuances (2020 - 2022)

Updated

Rani Therapeutics Holdings (RANI) reported Long-Term Debt Issuances of $14.9 million for Q4 2022, up 1.6% from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Long-Term Debt Issuances (2020 - 2022) Analysis & Trends

For FY2022, Rani Therapeutics Holdings posted Long-Term Debt Issuances of $29.57 million.

  • By year, Long-Term Debt Issuances came in at $1.72 million in FY2021 (-38.2%) and $2.78 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Rani Therapeutics Holdings 111.44 Mn -41.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 14.90 Mn
Mar 31, 2021 1.72 Mn
Dec 31, 2020 156,000.00
Sep 30, 2020 2.78 Mn
API Access

Rani Therapeutics Holdings Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=RANI&period=max&api_key=YOUR_API_KEY